Research programme: centrally acting opioid analgesics - ChironWellAlternative Names: HS-198
Latest Information Update: 25 Apr 2016
At a glance
- Originator ChironWells
- Class Morphinans
- Mechanism of Action Opioid receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pain
Most Recent Events
- 25 Apr 2016 Preclinical trials in Pain in Austria (Parenteral) prior to April 2016